Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0001493152-23-022727
Filing Date
2023-06-28
Accepted
2023-06-28 11:50:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 86249
  Complete submission text file 0001493152-23-022727.txt   87165
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)